Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Amphotericin-B-mediated reactivation of latent HIV-1 infection.

Jones J, Kosloff BR, Benveniste EN, Shaw GM, Kutsch O.

Virology. 2005 Jan 5;331(1):106-16.

2.

CD154-CD40-induced reactivation of latent HIV-1 infection.

Kutsch O, Levy DN, Kosloff BR, Shaw GM, Benveniste EN.

Virology. 2003 Sep 15;314(1):261-70.

3.

Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.

Márquez N, Calzado MA, Sánchez-Duffhues G, Pérez M, Minassi A, Pagani A, Appendino G, Diaz L, Muñoz-Fernández MA, Muñoz E.

Biochem Pharmacol. 2008 Mar 15;75(6):1370-80. doi: 10.1016/j.bcp.2007.12.004. Epub 2007 Dec 23.

PMID:
18241838
4.

High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.

Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F, Maréchal V.

AIDS. 2007 Jan 30;21(3):283-92.

PMID:
17255735
5.
6.

Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs.

Scheller C, Sopper S, Koutsilieri E, Ludwig S, Ter Meulen V, Jassoy C.

Ann N Y Acad Sci. 2003 Dec;1010:209-12.

PMID:
15033722
7.

HIV-1 reactivation after an oxidative stress mediated by different reactive oxygen species.

Piette J, Legrand-Poels S.

Chem Biol Interact. 1994 Jun;91(2-3):79-89. Review.

PMID:
8194137
8.
9.

Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.

Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, Sluis-Cremer N.

J Biol Chem. 2011 Jun 24;286(25):22211-8. doi: 10.1074/jbc.M110.180224. Epub 2011 Apr 29.

10.

Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.

Hori T, Barnor J, Huu TN, Morinaga O, Hamano A, Ndzinu J, Frimpong A, Minta-Asare K, Amoa-Bosompem M, Brandful J, Odoom J, Bonney J, Tuffour I, Owusu BA, Ofosuhene M, Atchoglo P, Sakyiamah M, Adegle R, Appiah-Opong R, Ampofo W, Koram K, Nyarko A, Okine L, Edoh D, Appiah A, Uto T, Yoshinaka Y, Uota S, Shoyama Y, Yamaoka S.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):288-93. doi: 10.1016/j.bbrc.2015.02.102. Epub 2015 Feb 26. Erratum in: Biochem Biophys Res Commun. 2015 Jun 12;461(4):702.

PMID:
25727021
11.
12.

As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H.

Antiviral Res. 2013 Dec;100(3):688-97.

PMID:
24416773
13.

Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Shishido T, Wolschendorf F, Duverger A, Wagner F, Kappes J, Jones J, Kutsch O.

J Virol. 2012 Sep;86(17):9055-69. doi: 10.1128/JVI.00793-12. Epub 2012 Jun 13.

14.

TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.

Thibault S, Imbeault M, Tardif MR, Tremblay MJ.

Virology. 2009 Jun 20;389(1-2):20-5. doi: 10.1016/j.virol.2009.04.019. Epub 2009 May 17.

15.

Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.

Xing S, Bullen CK, Shroff NS, Shan L, Yang HC, Manucci JL, Bhat S, Zhang H, Margolick JB, Quinn TC, Margolis DM, Siliciano JD, Siliciano RF.

J Virol. 2011 Jun;85(12):6060-4. doi: 10.1128/JVI.02033-10. Epub 2011 Apr 6.

16.

Regulation of human immunodeficiency virus-1 latency and its reactivation.

Verdin E.

Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

PMID:
19445107
17.

Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages.

Clayette P, Martin M, Beringue V, Dereuddre-Bosquet N, Adjou KT, Seman M, Dormont D.

Antimicrob Agents Chemother. 2000 Feb;44(2):405-7.

18.

Reactivation of latent human immunodeficiency virus 1 by human herpesvirus 6 infection.

Isegawa Y, Katahira J, Yamanishi K, Sugimoto N.

Acta Virol. 2007;51(1):13-20.

PMID:
17432939
19.

In vitro reactivation of latent HIV-1 by cytostatic bis(thiosemicarbazonate) gold(III) complexes.

Fonteh P, Meyer D.

BMC Infect Dis. 2014 Dec 11;14:680. doi: 10.1186/s12879-014-0680-3.

20.

Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.

Xing S, Bhat S, Shroff NS, Zhang H, Lopez JA, Margolick JB, Liu JO, Siliciano RF.

J Antimicrob Chemother. 2012 Feb;67(2):398-403. doi: 10.1093/jac/dkr496. Epub 2011 Dec 7.

Supplemental Content

Support Center